Clinical Trial Update: AF-FLOW Registry to Evaluate Electrographic Flow Mapping in Patients Undergoing Ablation for Atrial Fibrillation

View source ↗

Summary

A registry study evaluating electrographic flow mapping in patients undergoing ablation for atrial fibrillation has completed recruitment and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Cardiac Arrhythmias
• Heart Diseases

Snippet

Sponsor: Ablacon, Inc. | Conditions: Atrial Fibrillation, Persistent, Atrial Fibrillation | Status: COMPLETED | Results posted: 2025-04-10